These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35343032)

  • 1. Establishment of a monoclonal antibody against glycosylated CD271 specific for cancer cells in immunohistochemistry.
    Fujii K; Morita S; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Yamaguchi K; Abe J; Yamazaki T; Imai T; Sugamura K; Yasuda J; Satoh K; Sato I; Saito-Koyama R; Fujishima F; Sasano H; Kato Y; Matsuura K; Asada Y; Tamai K
    Cancer Sci; 2022 Aug; 113(8):2878-2887. PubMed ID: 35343032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271.
    Morita S; Mochizuki M; Shibuya-Takahashi R; Nakamura-Shima M; Yamazaki T; Imai T; Asada Y; Matsuura K; Kawamura S; Yamaguchi K; Yasuda J; Sugamura K; Katori Y; Satoh K; Tamai K
    Monoclon Antib Immunodiagn Immunother; 2020 Feb; 39(1):6-11. PubMed ID: 32069133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer.
    Nakazato A; Mochizuki M; Shibuya-Takahashi R; Fujimori H; Fujii K; Saijoh S; Morita S; Yamazaki T; Imai T; Sato I; Satoh K; Yamaguchi K; Sugamura K; Yasuda J; Matsuura K; Shojaku H; Asada Y; Tamai K
    Sci Rep; 2022 Oct; 12(1):17751. PubMed ID: 36273237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of CD271, a potential cancer stem cell marker associated with chemoresistance and metastatic capacity.
    Li S; Yue D; Chen X; Wang L; Li J; Ping Y; Gao Q; Wang D; Zhang T; Li F; Yang L; Huang L; Zhang Y
    Oncol Rep; 2015 Jan; 33(1):425-32. PubMed ID: 25351876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
    Turner JR; Odze RD; Crum CP; Resnick MB
    Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD271 defines a stem cell-like population in hypopharyngeal cancer.
    Imai T; Tamai K; Oizumi S; Oyama K; Yamaguchi K; Sato I; Satoh K; Matsuura K; Saijo S; Sugamura K; Tanaka N
    PLoS One; 2013; 8(4):e62002. PubMed ID: 23626764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells.
    Morita S; Mochizuki M; Wada K; Shibuya R; Nakamura M; Yamaguchi K; Yamazaki T; Imai T; Asada Y; Matsuura K; Sugamura K; Katori Y; Satoh K; Tamai K
    Cancer Lett; 2019 Oct; 461():144-152. PubMed ID: 31325530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of insulin-like growth factor II mRNA-binding protein 3 (IMP3) as a new marker for the diagnosis of esophageal adenocarcinoma in challenging cases.
    Kazeminezhad B; Mirafsharieh SA; Dinyari K; Azizi D; Ebrahimi A
    Turk J Gastroenterol; 2014 Jun; 25(3):253-6. PubMed ID: 25141312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do DLX3 and CD271 Protect Human Keratinocytes from Squamous Tumor Development?
    Palazzo E; Marconi A; Pincelli C; Morasso MI
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31331058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Synchronous Multiple Esophageal Cancers Composed of Squamous Cell Carcinoma and Barrett's Adenocarcinoma].
    Kobayashi T; Shiozaki A; Fujiwara H; Konishi H; Arita T; Kosuga T; Morimura R; Murayama Y; Komatsu S; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Okamoto K; Otsuji E
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1890-2. PubMed ID: 26805207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
    Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
    Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
    Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
    Feith M; Stein HJ; Mueller J; Siewert JR
    Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma.
    Fabian T; Leung A
    Surg Clin North Am; 2021 Jun; 101(3):381-389. PubMed ID: 34048759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas.
    Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD
    Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of chromoendoscopy with methylene blue in Barrett's metaplasia and early esophageal carcinoma.
    Ormeci N; Savas B; Coban S; Palabiyikoğlu M; Ensari A; Kuzu I; Kursun N
    Surg Endosc; 2008 Mar; 22(3):693-700. PubMed ID: 17704887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of Claudin-2 in esophageal carcinoma and precancerous lesions is significantly associated with the bile salt receptors VDR and TGR5.
    Abu-Farsakh S; Wu T; Lalonde A; Sun J; Zhou Z
    BMC Gastroenterol; 2017 Feb; 17(1):33. PubMed ID: 28212604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.
    Cawley HM; Meltzer SJ; De Benedetti VM; Hollstein MC; Muehlbauer KR; Liang L; Bennett WP; Souza RF; Greenwald BD; Cottrell J; Salabes A; Bartsch H; Trivers GE
    Gastroenterology; 1998 Jul; 115(1):19-27. PubMed ID: 9649454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycholic acid impairs glycosylation and fucosylation processes in esophageal epithelial cells.
    Byrne AM; Sharma R; Duggan G; Kelleher D; Long A
    Glycobiology; 2012 May; 22(5):638-48. PubMed ID: 22223758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.